-
1 Comment
Mangalam Drugs & Organics Limited is currently in a long term uptrend where the price is trading 28.8% above its 200 day moving average.
From a valuation standpoint, the stock is 89.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.5.
Mangalam Drugs & Organics Limited's total revenue sank by 71.3% to $887M since the same quarter in the previous year.
Its net income has dropped by 48.3% to $64M since the same quarter in the previous year.
Finally, its free cash flow fell by 0.0% to $81M since the same quarter in the previous year.
Based on the above factors, Mangalam Drugs & Organics Limited gets an overall score of 2/5.
| Exchange | NSE |
|---|---|
| CurrencyCode | INR |
| ISIN | INE584F01014 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | 1B |
|---|---|
| Target Price | None |
| PE Ratio | 12.75 |
| Beta | 0.97 |
| Dividend Yield | None |
Mangalam Drugs & Organics Limited, together with its subsidiary, manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers API products, including acyclovir, amodiaquine, artemether, artesunate, bisoprolol fumarate, chloroquine phosphate, dihydroartemisinin, dolutegravir sodium, efavirenz, emtricitabine, furosemide, hydroxychloroquine sulphate, lumefantrine, nimesulide, nitrofurantoin anhydrous and monohydrate, primaquine and piperaquine phosphate, pyrimethamine, pyronaridine tetraphosphate, sulfadoxine, tenofovir alafenamide hemifumarate, and tenofovir disoproxil fumarate. It also provides intermediates, such as 2-dibutylamino-1-(2,7-dichloro-9H-fluorine-4-yl)-ethanol; 4,6-dichloro-5-methoxy pyrimidine; 4,7 dichloroquinoline; and ortho phenoxy methane sulfonanilide, tenofovir alafenamide base, and tenofovir disoproxil base. In addition, the company offers specialty chemicals comprising l(+)menthol; 2,3-dihydrophthalazine-1, 4-dione or phthalazine-1,4-dione; and 4-cynoethyl-2-methy phenol; bictegravir Na, aripiprazole, risperidone, olanzapine, and etodolac; and develops tafenoquine succinate and pretomanid. Further, it manufactures organic and inorganic chemicals, and heavy chemicals. The company was incorporated in 1972 and is based in Mumbai, India.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for MANGALAM.NSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
